Effect of Alzheimer's Brain Extracts on Dynein Immunoreactivity in PC12 Cells

Experimental Biology and Medicine

Volumn 216, Issue 3, 1997, Pages 429-437

  Kopec, Karla ^a   Chambers, James P ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN EXTRACT; DYNEIN ADENOSINE TRIPHOSPHATASE;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; NERVE FIBER TRANSPORT;

ALZHEIMER DISEASE; AMMONIUM SULFATE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL COUNT; CELL FRACTIONATION; DYNEIN ATPASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KINESIN; MITOCHONDRIA; OXIDOREDUCTASES; PC12 CELLS; PHOSPHORYLATION; RATS; TAU PROTEINS; TISSUE EXTRACTS; TRYPSIN;

ANIMALIA;

EID: 0030834468     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44193     Document Type: Article

References (45)

1. Liberski PP. Transmissible cerebral amyloidoses as a model for Alzheimer's disease. An ultrastructural perspective. Mol Neurobiol 8:67-77, 1994.
2. Brion JP. The pathology of the neuronal cytoskeleton in Alzheimer's disease. Biochim Biophys Acta 1160:134-142, 1992.
3. Iqbal K, Grundke-Iqbal I. Ubiquination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Mol Neurobiol 5:399-410, 1991.
4. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 6:487-498, 1991.
5. Price DL. New perspectives on Alzheimer's disease. Annu Rev Neurosci 9:489-512, 1986.
6. Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 36:40-47, 1994.
7. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer's disease brain. Proc Natl Acad Sci U S A 89:1671-1675, 1992.
8. Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I. Mechanism of neurofibrillary degeneration in Alzheimer's disease. Mol Neurobiol 9:119-123, 1994.
9. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16:460-465, 1993.
10. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10:373-403, 1994.
11. Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890, 1984.
12. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084-6089, 1986.
13. Lee VMY, Baline BJ, Otvos JL, Trojanowski JQ. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675-678, 1991.
14. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B. Defective brain microtubule assembly in Alzheimer's disease. Lancet 2:421-426, 1986.
15. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein T (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913-4917, 1986.
16. Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci U S A 83:4044-4048, 1986.
17. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099, 1993.
18. Iqbal K, Zaidi T, Bancher C, Iqbal-Grundke I. Alzheimer paired helical filaments. Restoration of the biological activity dephosphorylation. FEBS Lett 349:104-108, 1994.
19. Holzbaur ELF, Vallee RB. Dyneins: Molecular structure and cellular function. Annu Rev Cell Biol 10:339-372, 1994.
20. Paschal BM, Shpeter HS, Vallee RB. MAP1C is a microtubule-activated ATPase which translocates microtubules in vitro and has dynein-like properties. J Cell Biol 105:1273-1282, 1987.
21. Vale RD, Reese TS, Scheetz MP. Identification of a novel force generating protein, kinesin, involved in microtubule-based motility. Cell 42:39-50, 1985.
22. Lin SXH, Collins CA. Immunolocalization of cytoplasmic dynein to lysosomes in cultured cells. J Cell Sci 101:125-137, 1992.
23. Corthesy-Theulaz I, Pauloin A, Pfeffer SR. Cytoplasmic dynein participates in the centrosomal localization of the golgi complex. J Cell Biol 118:1333-1345, 1992.
24. Aniento F, Emans N, Griffiths G, Gruenburg J. Cytoplasmic dynein-dependent vesicular transport from early to late endosomes. J Cell Biol 123:1373-1387, 1993.
25. Xiang X, Beckwith SM, Morris NR. Cytoplasmic dynein is involved in nuclear migration in Aspergillus nidulans. Proc Natl Acad Sci U S A 91:2100-2104, 1994.
26. Gong C-X, Singh TJ, Grundle-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61:921-927, 1993.
27. Wang H-Y, Pisano MR, Friedman E. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol Aging 15:293-298, 1994.
28. Greene LA, Tischler AS. Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which responds to nerve growth factor. Proc Natl Acad Sci U S A 73:2424-2428, 1976.
29. Shafer TJ, Atchison WD. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: A model for neurotoxicological studies. Neurotoxicology 12:473-492, 1991.
30. Ulloa L, Montejo de Garcini E, Gomez-Ramos P, Moran MA, Avila J. Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. Brain Res Mol Brain Res 26:113-122, 1994.
31. Downs TR, Wilfinger WW. Fluorometric quantification of DNA in cells and tissue. Anal Biochem 131:538-547, 1983.
32. West DC, Sattar A, Kumar S. A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal Biochem 147:289-295, 1985.
33. Steuer ER, Wordeman TA, Schroer TA, Sheetz MP. Localization of cytoplasmic dynein to mitotic spindles and kinetochores. Nature 345:266-268, 1990.
34. Uchida Y, Tomonaga M. Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons. Brain Res 481:190-193, 1989.
35. 4. Nature 227:680-685, 1970.
36. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
37. Pfister KK, Salata MW, Dillman JF, Vaughan KT, Vallee RB, Torre E, Lye RJ. Differential expression and phosphorylation of the 74-kDa intermediate chains of cytoplasmic dynein in cultured neurons and glia. J Biol Chem 271:1687-1694, 1996.
38. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neu- rodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13:1676-1687, 1993.
39. Behl C, Davis JB, Cole GM, Schubert D. Vitamin E protects nerve cells from Amyloid β Protein toxicity. Biochem Biophys Res Commun 186:944-950, 1992.
40. Shearman MS, Ragan CI, Iversen LL. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci U S A 91:1470-1474, 1994.
41. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A 90:7951-7955, 1993.
42. Scott AS, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15:6213-6221, 1995.
43. Jette N, Cole MS, Fahnestock M. NGF mRNA is not decreased in frontal cortex from Alzheimer disease patients. Brain Res Mol Brain Res 25:242-250, 1994.
44. Ekman P, Jager O. Quantitation of subnanomolar amounts of phosphate bound to seryl and threonyl residues in phosphoproteins using alkaline hydrolysis and malachite green. Anal Biochem 214:138-141, 1993.
45. Green AA, Hughes WL. Protein fractionation on the basis of solubility in aqueous solutions of salts and organic solvents. Methods Enzymol 1:67-90, 1955.